Siren Biotechnology, Inc. — Form D
Siren Biotechnology, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-22. The offering totals $32.4M, of which $19.6M was reported sold. Industry: Other.
Offering
- Filed: 2024-04-22
- Form: D
- Accession: 0002020584-24-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $32.4M
- Amount sold: $19.6M
- Remaining: $12.8M
- Investors: 57
- Date of first sale: 2024-04-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-511190
Issuer
- Name: Siren Biotechnology, Inc.
- CIK: 0002020584
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Phone: 628-758-8536
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Brad Allen | Director | Salt Lake City, UT |
| Nicole Paulk | Director | San Francisco, CA |
| Sharon Tetlow | Director | San Francisco, CA |
| Nicole Paulk | Executive Officer | San Francisco, CA |
More